STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$31.20 USD
-0.29 (-0.92%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $31.22 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum C VGM
Income Statements
Fiscal Year end for STAAR Surgical Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 322 | 284 | 230 | 163 | 150 |
Cost Of Goods | 70 | 61 | 52 | 45 | 38 |
Gross Profit | 253 | 223 | 179 | 118 | 112 |
Selling & Adminstrative & Depr. & Amort Expenses | 225 | 180 | 145 | 112 | 100 |
Income After Depreciation & Amortization | 28 | 44 | 33 | 7 | 12 |
Non-Operating Income | 6 | 2 | -2 | 2 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 34 | 46 | 31 | 8 | 13 |
Income Taxes | 12 | 7 | 7 | 2 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 21 | 39 | 25 | 6 | 14 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 21 | 39 | 25 | 6 | 14 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 31 | 47 | 37 | 10 | 16 |
Depreciation & Amortization (Cash Flow) | 3 | 3 | 4 | 3 | 4 |
Income After Depreciation & Amortization | 28 | 44 | 33 | 7 | 12 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 49.43 | 49.38 | 49.46 | 47.95 | 46.90 |
Diluted EPS Before Non-Recurring Items | 0.67 | 0.81 | 0.58 | 0.35 | 0.46 |
Diluted Net EPS (GAAP) | 0.43 | 0.78 | 0.50 | 0.12 | 0.30 |
Fiscal Year end for STAAR Surgical Company falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 99.01 | 77.36 | 76.27 | 80.31 | 92.31 |
Cost Of Goods | 20.59 | 16.32 | 15.55 | 16.67 | 21.58 |
Gross Profit | 78.41 | 61.04 | 60.73 | 63.64 | 70.73 |
SG&A, R&D, and Dept/Amort Expenses | 66.51 | 63.32 | 50.32 | 57.34 | 62.13 |
Income After SG&A, R&D, and Dept/Amort Expenses | 11.90 | -2.28 | 10.41 | 6.30 | 8.60 |
Non-Operating Income | -1.56 | 0.07 | 3.33 | 0.45 | -0.11 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 10.33 | -2.21 | 13.74 | 6.75 | 8.49 |
Income Taxes | 2.96 | 1.13 | 5.98 | 1.93 | 2.43 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 7.38 | -3.34 | 7.76 | 4.82 | 6.06 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 7.38 | -3.34 | 7.76 | 4.82 | 6.06 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 49.81 | 48.91 | 49.24 | 49.37 | 49.52 |
Diluted EPS Before Non-Recurring Items | 0.15 | -0.07 | 0.24 | 0.13 | 0.23 |
Diluted Net EPS (GAAP) | 0.15 | -0.07 | 0.16 | 0.10 | 0.12 |